Patent Claim Amendment

A claim amendment is a change to the language of one or more patent claims submitted to the USPTO during prosecution: TYPES OF CLAIM AMENDMENTS: (a) NARROWING AMENDMENT: adds a limitation to a claim, making it narrower in scope; the most common type — used to distinguish over prior art rejections; (b) BROADENING AMENDMENT: removes a limitation or broadens the scope of an existing limitation; only possible before the patent issues (or in a reissue application); (c) CLARIFYING AMENDMENT: changes the wording without changing the scope (e.g., fixing an antecedent basis problem, correcting a typographical error); WHEN AMENDMENTS ARE MADE: (a) In response to a non-final office action: the applicant has the right to amend claims and argue against rejections; examiner must consider all amendments; (b) In response to a final rejection: amendments after final are submitted as 'after final' amendments; they must meet at least one of three standards to be entered by the examiner; (c) Before examination: a preliminary amendment filed before first action; (d) In an RCE (Request for Continued Examination): filing an RCE with an amendment reopens prosecution and the examiner must consider the amendment; (e) At allowance: a formal amendment to put the application in condition for allowance (fixing formalities); FORMAL REQUIREMENTS: amendments use a specific USPTO format; claim amendments use markup (strikethrough for deletions, underline for additions) on the first amendment; subsequent amendments restate the claim in clean form; 37 C.F.R. § 1.121 governs the format; NO NEW MATTER RULE: 35 U.S.C. § 132 prohibits any amendment that introduces 'new matter' — subject matter not originally disclosed in the application; adding a new claim covering an embodiment not in the original specification is not permitted.

Prosecution history estoppel is a doctrine that limits the doctrine of equivalents based on narrowing amendments made during prosecution: THE DOCTRINE OF EQUIVALENTS: the DOE allows a patent owner to prove infringement even when an accused product doesn't literally meet a claim element, if the accused feature is substantially equivalent (same function, same way, same result); PROSECUTION HISTORY ESTOPPEL (PHE): when the patent owner narrows a claim by amendment to overcome a prior art rejection, they are estopped (barred) from later asserting the DOE to recapture the scope given up by the amendment; FESTO CORP. v. SHOKETSU KINZOKU (S.Ct. 2002): the Supreme Court adopted a REBUTTABLE PRESUMPTION that a narrowing amendment surrenders ALL equivalent subject matter relating to the element that was amended; WHAT TRIGGERS THE PRESUMPTION: (a) a narrowing amendment that (b) was made for a SUBSTANTIAL REASON RELATED TO PATENTABILITY (a 'substantive' amendment); an amendment made solely for reasons unrelated to patentability (e.g., to comply with USPTO formalities) does not trigger PHE; REBUTTING THE PRESUMPTION: the patent owner can rebut the presumption of surrender by showing: (a) the equivalent was UNFORESEEABLE at the time of the amendment — the equivalent was not known to exist at the time the amendment was made; (b) the RATIONALE for the amendment bears NO MORE THAN A TANGENTIAL RELATION to the equivalent — the amendment was made for reasons unrelated to the specific equivalent at issue; (c) there was SOME OTHER REASON for the amendment such that the patent owner could not reasonably be expected to have described the equivalent; ESTOPPEL APPLIES TO ARGUMENTS ALONE: prosecution disclaimer can also arise from arguments made to distinguish prior art (even without a formal amendment); clear and unambiguous disclaimers of claim scope in prosecution arguments can limit claim construction.

The no-new-matter rule is one of the most frequently litigated issues in patent prosecution: THE RULE: 35 U.S.C. § 132: 'No amendment shall introduce new matter into the disclosure of the invention'; new matter is any subject matter not supported by the application as originally filed (the original specification, claims, and drawings); WHAT IS 'NEW MATTER': (a) a claim limitation that is not described in the original specification; (b) a new drawing that shows features not in the original drawings; (c) a new example that is not disclosed in the original specification; (d) a new relationship between described elements that is not described or implied in the original specification; WHAT IS NOT 'NEW MATTER': (a) clarifying amendments that make explicit what is reasonably implicit in the original disclosure; (b) amendments that narrow a claim to a subset of what is disclosed (as long as the subset is described); (c) adding a claim that describes an embodiment already described in the specification; SUPPORT REQUIREMENT: every limitation in every claim must find written description support in the specification; this is separate from the no-new-matter rule but related — an amendment that adds a limitation with no specification support is new matter AND fails written description; DRAWINGS AS SUPPORT: drawings can provide written description support for claim limitations; but a dimension shown in a drawing may provide support only if a POSITA would reasonably understand the drawing to disclose the precise dimension; IN CONTINUATION APPLICATIONS: a continuation application has the same parent specification; new matter in the continuation would not receive the parent's filing date — it would be new matter limited to the continuation's filing date; CIP APPLICATIONS: a continuation-in-part (CIP) explicitly adds new matter beyond the parent; the new matter gets only the CIP's priority date; claims in the CIP directed to new matter are prior art for anything before the CIP's actual filing date.

Experienced patent practitioners use specific strategies to overcome rejections while minimizing prosecution history estoppel: STRATEGY 1 — ARGUE FIRST, AMEND SECOND: when an examiner issues a § 103 rejection, argue that the references cannot be combined or that the primary reference doesn't teach the claimed element; if the argument is accepted, there is no amendment and no estoppel; only amend when argument alone is insufficient; STRATEGY 2 — MINIMUM NECESSARY AMENDMENT: when amendment is necessary, add the minimum limitation that overcomes the rejection; avoid adding extra limitations that further restrict the claim; each unnecessary narrowing creates additional estoppel; STRATEGY 3 — DEPENDENT CLAIMS AS FALLBACK: maintain dependent claims with various specific embodiments; if the independent claim is invalidated or too narrow to cover a competitor's product, dependent claims with different claim language may capture it; STRATEGY 4 — CLAIM DIFFERENTIATION: draft the independent claim broadly and add dependent claims that recite specific features; avoids adding those features to the independent claim (and creating estoppel) while preserving the narrower scope in dependent claims; STRATEGY 5 — PROSECUTION DISCLAIMER THROUGH ARGUMENTS: if you must limit the scope of a claim, do it through the CLAIMS (creating estoppel only for what was literally surrendered) rather than through ARGUMENTS (which can create broader disclaimers if not carefully worded); arguments that distinguish prior art on narrow grounds can create broader disclaimers than intended; STRATEGY 6 — CONTINUATION APPLICATIONS: file a continuation application to pursue broader or differently scoped claims without the estoppel baggage of the parent prosecution; the continuation can pursue claims that might have been broader than the parent's final claims; STRATEGY 7 — DOCUMENT THE REASONS FOR AMENDMENTS: the Festo presumption of total surrender can be rebutted if the amendment was for reasons other than patentability; document why an amendment was made in the office action response (e.g., 'This amendment is made to clarify antecedent basis, not to overcome a prior art rejection').

During inter partes review (IPR) proceedings at the PTAB, patent owners have a limited opportunity to amend claims — but the rules are much more restrictive than during prosecution: STATUTORY BASIS: 35 U.S.C. § 316(d): during an IPR trial, the patent owner may file ONE motion to amend the patent; the motion may: (a) cancel any challenged patent claim; (b) propose a reasonable number of substitute claims; PROCEDURAL HISTORY: motions to amend were initially very difficult to obtain in IPRs; PTAB initially applied very strict standards and denied most motions; Aqua Products v. Matal (Fed. Cir. 2017 en banc): shifted the burden of proof to the petitioner to show the proposed substitute claims are unpatentable; subsequent PTAB rule changes further modified the procedure; SUBSTITUTE CLAIMS — REQUIREMENTS: (a) NARROWING ONLY: the substitute claim must be narrower than the original claim it replaces; it cannot be broader; (b) NO NEW MATTER: the substitute claim cannot add subject matter not disclosed in the application as originally filed; (c) RESPONSIVE TO GROUND OF UNPATENTABILITY: the substitute claim must directly respond to the ground of unpatentability at issue (e.g., adding a limitation that distinguishes over the prior art cited in the IPR petition); (d) REASONABLE NUMBER: the patent owner can propose a reasonable number of substitute claims; the default is one substitute for each original claim challenged; OPPOSITION: the petitioner can oppose the motion to amend; the opposition must show the substitute claims are unpatentable; USPTO DIRECT ASSESSMENT: after Hunting Titan (precedential): the PTAB can independently assess patentability of substitute claims even if the petitioner does not oppose; GRANT RATE: motions to amend are granted in approximately 15-25% of IPRs; low success rate reflects the stringent requirements and the adversarial challenge from petitioners; PROSECUTION AMENDMENT vs. IPR AMENDMENT: prosecution amendment = applicant adds claims and argues for them; no estoppel issue (the patent hasn't issued yet); IPR amendment = patent owner proposes substitute claims to replace challenged claims; creates estoppel for surrendered scope.